PRECIGEN Investors

Maximizing Value for Investors

Precigen operates under a set of core principles that allow us to deliver value to all stakeholders: Fiscal Strength, Active Portfolio Management, Rapid Execution, Strategic Partnerships.

Maximizing Value for Investors

Nasdaq: PGEN

Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.

btn2 Stock

View All